IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison Report
Performance
Performance Report
Sai Life Sciences IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 3042.62 Cr. The company is based in Hyderabad and caters to Chemical sector. IIFL Securities , Jefferies India , Kotak Mahindra Capital Company , Morgan Stanley India Company are the merchant bankers of Sai Life Sciences IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 29th July 2024.
Sai Life Sciences IPO posted revenues of ₹ 1386.70 crores and PAT of ₹ 56.02 crores in FY25 on annualised basis.
Revenue:
₹ 1,350.40 Cr.
EBITDA Margin:
20.66
% 
Net Worth: ₹ 1045.50 Cr.
Market Capitalisation:
₹ 11418.63 Cr.
P/E:
203.82 times
P/BV: 2.79 times
EV/EBITDA: 43.49 times
Financial results of Sai Life Sciences IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Sep-24 | FY24 | FY23 | FY22 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 2476.70 | 2275.10 | 2186.60 | 2164.20 | |
| Net Worth | 1045.50 | 975.10 | 888.00 | 878.50 | |
| Total Debt | 764.30 | 710.10 | 699.10 | 751.20 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
675.20
1,350.40 |
1465.10 | 1217.10 | 869.50 | |
EBITDA
EBITDA on annualised basis |
139.50
279.00 |
300.10 | 182.20 | 131.00 | |
PAT
PAT on annualised basis |
28.00
56.00 |
82.80 | 9.90 | 6.20 | |
Sai Life Sciences IPO PAT Margin is 4.15 % , ROCE (Return on Capital Employed) is 3.90 % as per latest financial. The below table shows Sai Life Sciences IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Sep-24 | FY24 | FY23 | FY22 |
|---|---|---|---|---|
| EBITDA Margin (%) | 20.66 | 20.48 | 14.97 | 15.07 |
| PAT Margin (%) | 4.15 | 5.65 | 0.81 | 0.71 |
| EPS (₹) | 1.50 | 4.57 | 0.55 | 0.35 |
| ROE (%) | 2.68 | 8.49 | 1.11 | 0.71 |
| ROCE (%) | 3.90 | 10.26 | 5.13 | 3.21 |
| ROA (%) | 1.13 | 3.64 | 0.45 | 0.29 |
| Debt to Equity | 0.73 | 0.73 | 0.79 | 0.86 |
The market Capitalisation of Sai Life Sciences IPO is ₹ 11418.63 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Sai Life Sciences IPO prospectus highlights an Return on Equity (ROE) of 2.68 % , Return on Assets (ROA) of 1.13 %, and an EBITDA Margin of 20.66 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Sai Life Sciences IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Sai Life Sciences IPO is ₹ 11418.63 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Sai Life Sciences IPO has a Price-to-Earnings (PE) ratio of 203.82 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Sai Life Sciences IPO reported revenue of ₹ 1386.70 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Sai Life Sciences IPO provide insights into sales growth, market demand, and business scalability.
Sai Life Sciences recorded an EBITDA of ₹ 279.00 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Sai Life Sciences Profit After Tax (PAT) is ₹ 56.00 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 1,350.40 Cr.
EBITDA Margin:
20.66
%
Net Worth: ₹ 1045.50 Cr.
Market Capitalisation:
₹ 11418.63 Cr.
P/E:
203.82 times
P/BV: 2.79 times
EV/EBITDA: 43.49 times
Sai Life Sciences operates in Chemical and Offers Tailor-made Services To Biotech Firms And Global Pharma Companies.. The Issue is listed on BSE,NSE in Dec, 2024. Sai Life Sciences IPO size was 3042.62 with Issue price of 549.00 .
Merchant Banker(s) of Sai Life Sciences IPO: IIFL Securities Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited , Morgan Stanley India Company Private Limited
Sai Life Sciences IPO subscription was 10.27 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Sai Life Sciences IPO listed at a listing price of 764.65 against the offer price of 549.00.
The current market price of Sai Life Sciences is 779.80.
Why Us?
